Skip to main content
. 2021 Jul 12;8(1):e000528. doi: 10.1136/lupus-2021-000528

Figure 1.

Figure 1

Flow chart of patients included or not in the study. Negative patients had a multianalyte assay panel (MAP) score <−0.1; low tier-2 had a score >0.1 and ≤1; high tier-2 had a score >1; for the tier-1 positives, the score was not calculated as they met the criteria of tier-1 positivity.